Accretion Pharmaceuticals

Accretion Pharmaceuticals

56.15
+0.85
(1.54%)
hide
Key Fundamentals
Add Ratio
Market Cap
61.50 Cr
EPS
8.48
PE Ratio
9.05
Dividend Yield
0.00 %
Industry
-
52 Week High
82.95
52 Week Low
53.80
PB Ratio
1.36
Debt to Equity
1.33
Sector
-
Forecast For
Actual

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
329.10 %
Net Income Growth
353.33 %
Cash Flow Change
149.96 %
ROE
63.50 %
ROCE
238.94 %
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2024
2025
TTM
Revenue
13
58
0
Expenses
11
46
0
EBITDA
3
12
0
Operating Profit %
20 %
21 %
0 %
Depreciation
0
1
0
Interest
1
1
0
Profit Before Tax
2
10
0
Tax
1
3
0
Net Profit
2
7
0
EPS in ₹
11.08
8.48
0.00

Balance Sheet

Balance Sheet
2024
2025
Total Assets
27
40
Fixed Assets
5
6
Current Assets
22
34
Capital Work in Progress
0
0
Investments
0
0
Other Assets
22
34
Total Liabilities
27
40
Current Liabilities
15
23
Non Current Liabilities
7
1
Total Equity
6
15
Reserve & Surplus
2
7
Share Capital
4
8

Cash Flow

Cash Flow
2024
2025
Net Cash Flow
0
0
Investing Activities
-6
-2
Operating Activities
-12
6
Financing Activities
17
-4

Share Holding

% Holding
Sept 2024
Jan 2025
May 2025
Jun 2025
Promoter
100.00 %
100.00 %
73.50 %
73.50 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
19.44 %
21.46 %
Others
0.00 %
0.00 %
7.06 %
5.04 %
No of Share Holders
8
8
8
1,628

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
11 Jun 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Jun 2025 66.05 69.80

Technical Indicators

RSI(14)
Neutral
33.67
ATR(14)
Less Volatile
1.61
STOCH(9,6)
Neutral
36.66
STOCH RSI(14)
Oversold
18.36
MACD(12,26)
Bearish
-0.36
ADX(14)
Strong Trend
36.31
UO(9)
Bearish
51.22
ROC(12)
Downtrend And Accelerating
-3.66
WillR(14)
Neutral
-73.91